Table 3.
Baseline |
6 Months |
|||||
---|---|---|---|---|---|---|
% volume of significant correlated area (PSV) | % difference of significant correlated area (APD) | Average p-value of significant correlated area | % volume of significant correlated area (PSV) | % difference of significant correlated area (APD) | Average p-value of significant correlated area | |
MF | 15.4 | 18.2 | 0.02 | 33.8 | 19.5 | 0.02 |
MT | 13.5 | 21.5 | 0.02 | 11.7 | 22.4 | 0.03 |
LF | 8.5 | 20.4 | 0.02 | 8.5 | 20.3 | 0.03 |
LT | 27.4 | 27.8 | 0.02 | 22.4 | 25.2 | 0.02 |
TrF | 0.8 | 16.8 | 0.03 | 10.3 | 24.2 | 0.02 |
P | 2.1 | 24.9 | 0.03 | 0.3 | 17.6 | 0.03 |
MF, medial femoral condyle; MT, medial tibia; LF, lateral femoral condyle; LT, lateral tibia; TrF, trochlea; P, patella. A positive APD indicates that the T1ρ relaxation times are higher in the group with baseline lesions than thegroup without lesions.